<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=The_Undetectable_Jewelry_Of_PD0325901</id>
		<title>The Undetectable Jewelry Of PD0325901 - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=The_Undetectable_Jewelry_Of_PD0325901"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=The_Undetectable_Jewelry_Of_PD0325901&amp;action=history"/>
		<updated>2026-07-05T21:39:39Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=The_Undetectable_Jewelry_Of_PD0325901&amp;diff=80107&amp;oldid=prev</id>
		<title>Brianoffice0 : Page créée avec « The age distributions in the UGIB group were 2-5 years in 11 cases (29.7%) and &gt;10 years in 10 cases (27.0%), while that in the LGIB group was 6-10 years in 6 cases (42.9%... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=The_Undetectable_Jewelry_Of_PD0325901&amp;diff=80107&amp;oldid=prev"/>
				<updated>2017-03-20T06:48:29Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « The age distributions in the UGIB group were 2-5 years in 11 cases (29.7%) and &amp;gt;10 years in 10 cases (27.0%), while that in the LGIB group was 6-10 years in 6 cases (42.9%... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The age distributions in the UGIB group were 2-5 years in 11 cases (29.7%) and &amp;gt;10 years in 10 cases (27.0%), while that in the LGIB group was 6-10 years in 6 cases (42.9%) (Fig. 1). Fig. 1 Age distribution of enrolled patients. UGIB: upper gastrointestinal bleeding, LGIB: lower gastrointestinal bleeding. Type I melena was observed in 37 cases (61.7%) and type II in 15 cases (25.0%). Sixty cases were composed of 35 UGIB cases (58.3%), 14 LGIB cases (23.3%), and 11 undiagnosed cases (18.3%) (Table 1). Table 1 Clinical Characteristics of Study Population (n=60) Clinical features and causes of UGIB or LGIB in melena patients Of 35 cases with UGIB, 25 cases (71.4%) had type I melena, and 7 cases (20.0%) with type II melena. Type II melena was observed in 15 (25.0%) of the enrolled cases that were composed of 7 cases (20.0%) in the [http://www.selleckchem.com/products/PD-0325901.html PD0325901] UGIB group, and 7 cases (50.0%) in the LGIB group, with a significant difference (p=0.038, Table 2). Table 2 Clinical Features, Diagnostic Modalities and Treatments of Patients Diagnosed with [http://www.selleckchem.com/products/epz-6438.html EPZ6438] Upper Gastrointestinal Bleeding (UGIB) or Lower Gastrointestinal Bleeding (LGIB) Presented with Melena The two common causes were varices in 13 cases (37.1%) and PUD in 11 cases (31.4%) in UGIB. Meckel's diverticulum, the most common in LGIB, accounted for 12 cases (85.7%) (Table 1 and Fig. 2). Fig. 2 Etiologies of patients with melena due to gastrointestinal bleeding. Type I: passage of tarry black stool only, type II: passage of tarry black stool mixed with or preexisting fresh blood, unclassified: cannot classify stool whether type I or II, UGIB: ... Diagnostic methods and therapeutic modalities of the subjects The diagnostic tests were as follows: [http://en.wikipedia.org/wiki/GRB10 GRB10] for UGIB group, esophagogastroduodenoscopy (EGD) was used in 35 cases (100.0%); and for LGIB group, Meckel's scan in 11 cases (78.6%), capsule endoscopy in 1 case (7.1%), colonoscopy in 1 case (7.1%), and abdominal computed tomography in 1 case (7.1%), respectively. As the therapeutic modality in UGIB group, medication was used in 22 cases (62.9%); endoscopic intervention in 8 cases (22.9%); and surgery in 5 cases (14.3%). In the LGIB group, surgery was done in 13 cases (92.9%), and endoscopic intervention in 1 case (7.1%) (Table 2). Laboratory results of melena patients as UGIB or LGIB The median hemoglobin level in the UGIB group was 8.5 g/dL (1.7-13.2), and in the LGIB group, 7.7 g/dL (4.2-10.5). Hb&lt;/div&gt;</summary>
		<author><name>Brianoffice0</name></author>	</entry>

	</feed>